1. A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines. Issue 4 (29th April 2019) Authors: Hirakawa, Akihiro; Sudo, Kazuki; Yonemori, Kan; Sadachi, Ryo; Kinoshita, Fumie; Kobayashi, Yumiko; Okuma, Hitomi S.; Kawachi, Asuka; Tamura, Kenji; Fujiwara, Yasuhiro; Rubinstein, Larry; Takebe, Naoko Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 4(2019) Page Start: 803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Issue 11 (4th September 2019) Authors: Takebe, Naoko; Beumer, Jan H.; Kummar, Shivaani; Kiesel, Brian F.; Dowlati, Afshin; O'Sullivan Coyne, Geraldine; Piekarz, Richard; Rubinstein, Lawrence; Fogli, Laura K.; Vaishampayan, Ulka; Goel, Sanjay; O'Bryant, Cindy L.; El‐Rayes, Bassel F.; Chung, Vincent; Lenz, Heinz‐Josef; Kim, Richard; Bel... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 11(2019) Page Start: 2499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial. Issue 20 (10th July 2022) Authors: Parsons, D. Williams; Janeway, Katherine A.; Patton, David R.; Winter, Cynthia L.; Coffey, Brent; Williams, P. Mickey; Roy-Chowdhuri, Sinchita; Tsongalis, Gregory J.; Routbort, Mark; Ramirez, Nilsa C.; Saguilig, Lauren; Piao, Jin; Alonzo, Todd A.; Berg, Stacey L.; Fox, Elizabeth; Hawkins, Douglas... Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial. Issue 20 (10th July 2022) Authors: Parsons, D. Williams; Janeway, Katherine A.; Patton, David R.; Winter, Cynthia L.; Coffey, Brent; Williams, P. Mickey; Roy-Chowdhuri, Sinchita; Tsongalis, Gregory J.; Routbort, Mark; Ramirez, Nilsa C.; Saguilig, Lauren; Piao, Jin; Alonzo, Todd A.; Berg, Stacey L.; Fox, Elizabeth; Hawkins, Douglas... Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018) Authors: Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Drug delivery of oral anti-cancer fluoropyrimidine agents. (2nd December 2017) Authors: Miura, Koh; Shima, Hiroshi; Takebe, Naoko; Rhie, Julie; Satoh, Kennichi; Kakugawa, Yoichiro; Satoh, Masayuki; Kinouchi, Makoto; Yamamoto, Kuniharu; Hasegawa, Yasuhiro; Kawai, Masaaki; Kanazawa, Kousuke; Fujiya, Tsuneaki; Unno, Michiaki; Katakura, Ryuichi Journal: Expert opinion on drug delivery Issue: Volume 14:Number 12(2017:Dec.) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Drug induced interstitial lung disease in oncology phase I trials. Issue 12 (December 2016) Authors: Yonemori, Kan; Hirakawa, Akihiro; Kawachi, Asuka; Kinoshita, Fumie; Okuma, Hitomi; Nishikawa, Tadaaki; Tamura, Kenji; Fujiwara, Yasuhiro; Takebe, Naoko Journal: Cancer science Issue: Volume 107:Issue 12(2016) Page Start: 1830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials. Issue 10351 (13th August 2022) Authors: Chihara, Dai; Lin, Ruitao; Flowers, Christopher R; Finnigan, Shanda R; Cordes, Lisa M; Fukuda, Yoko; Huang, Erich P; Rubinstein, Larry V; Nastoupil, Loretta J; Ivy, S Percy; Doroshow, James H; Takebe, Naoko Journal: Lancet Issue: Volume 400:Issue 10351(2022) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program–sponsored phase I trials. (July 2019) Authors: Kishimoto, Shun; Oshima, Nobu; Rinker, Matthew; Krishna, Murali C.; Takebe, Naoko Journal: European journal of cancer Issue: Volume 115(2019) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine Trial. Issue 4 (4th July 2019) Authors: Khan, Sabrina S.; Chen, Alice P.; Takebe, Naoko Journal: Expert review of precision medicine and drug development Issue: Volume 4:Issue 4(2019) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗